Sara Cacciapuoti

Via S. Pansini 5
Naples, 80131, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 86 publications

Reducing diagnostic delays of extraintestinal manifestations in inflammatory bowel disease: a comparative study of a multidisciplinary outpatient clinic versus conventional referral specialists.

Reducing diagnostic delays of extraintestinal manifestations in inflammatory bowel disease: a comparative study of a multidisciplinary outpatient clinic versus conventional referral specialists.

Journal: Therapeutic advances in gastroenterology

Published: October 29, 2024

Impact of tildrakizumab on the quality of life of patients with moderate-to-severe psoriasis: a 36-week prospective monocentric real-life observational study.

Impact of tildrakizumab on the quality of life of patients with moderate-to-severe psoriasis: a 36-week prospective monocentric real-life observational study.

Journal: Clinical and experimental dermatology

Published: September 11, 2024

ChatGPT and dermatology.

ChatGPT and dermatology.

Journal: Italian journal of dermatology and venereology

Published: July 23, 2024

Rapid Efficacy of riSankizumab in pretibial psoriasis invOLVEment: RESOLVE.

Rapid Efficacy of riSankizumab in pretibial psoriasis invOLVEment: RESOLVE.

Journal: Drugs in context

Published: June 13, 2024

Short-term efficacy of tildrakizumab on difficult-to-treat areas: a real-world experience.

Short-term efficacy of tildrakizumab on difficult-to-treat areas: a real-world experience.

Journal: International journal of dermatology

Published: May 27, 2024

Asymptomatic microscopic colitis induced by secukinumab.

Asymptomatic microscopic colitis induced by secukinumab.

Journal: JAAD case reports

Published: May 15, 2024

CorrespondenceAuthor reply to 'Comment on ChatGPT and medical writing in dermatology: why should we keep writing?' by Duff et al.

CorrespondenceAuthor reply to 'Comment on ChatGPT and medical writing in dermatology: why should we keep writing?' by Duff et al.

Journal: Clinical and experimental dermatology

Published: May 01, 2024

Author reply to 'Comment on ChatGPT and medical writing in dermatology: why should we keep writing?'

Author reply to 'Comment on ChatGPT and medical writing in dermatology: why should we keep writing?'

Journal: Clinical and experimental dermatology

Published: May 01, 2024

Real-Life Effectiveness and Safety of Guselkumab in Patients with Psoriasis Who Have an Inadequate Response to Ustekinumab: A 3-Year Multicenter Study.

Real-Life Effectiveness and Safety of Guselkumab in Patients with Psoriasis Who Have an Inadequate Response to Ustekinumab: A 3-Year Multicenter Study.

Journal: Journal of clinical medicine

Published: March 25, 2024

ChatGPT and medical writing in dermatology: why should we keep writing?

ChatGPT and medical writing in dermatology: why should we keep writing?

Journal: Clinical and experimental dermatology

Published: March 11, 2024

Biological Therapy for Psoriasis in Cancer Patients: An 8-Year Retrospective Real-Life Study.

Biological Therapy for Psoriasis in Cancer Patients: An 8-Year Retrospective Real-Life Study.

Journal: Journal of clinical medicine

Published: February 22, 2024

Effectiveness and Safety of Tildrakizumab in Psoriasis Patients Who Failed Anti-IL17 Treatment: A 28-Week Real-Life Study.

Effectiveness and Safety of Tildrakizumab in Psoriasis Patients Who Failed Anti-IL17 Treatment: A 28-Week Real-Life Study.

Journal: Clinical, cosmetic and investigational dermatology

Published: February 16, 2024

Showing 1-12 of 86

Last Updated: 09/26/2026